Exact Mass: 423.4076078

Exact Mass Matches: 423.4076078

Found 47 metabolites which its exact mass value is equals to given mass value 423.4076078, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Nervonoyl Glycine

2-(tetracos-15-enamido)acetic acid

C26H49NO3 (423.3712244000001)


N-nervonoyl glycine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Glycine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Glycine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Glycine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Semiplenamide D

N-(2-methyl-2Z-eicosenoyl)-1S-methyl-2-acetoxyethylamine

C26H49NO3 (423.3712244000001)


   

aberiamine|N1-hexyl-N1-pentyl-10-(1,3-dimethylhexahydro-2-pyrimidinyl)-1-decanamine

aberiamine|N1-hexyl-N1-pentyl-10-(1,3-dimethylhexahydro-2-pyrimidinyl)-1-decanamine

C27H57N3 (423.45522420000003)


   

benzyldimethylstearylammonium chloride

benzyldimethylstearylammonium chloride

C27H50ClN (423.36315700000006)


   

2,2,6,6-Tetramethyl-4-piperidinyl stearate

2,2,6,6-Tetramethyl-4-piperidinyl stearate

C27H53NO2 (423.4076078)


   

Octacosanoate

Octacosanoate

C28H55O2- (423.42018299999995)


A straight-chain saturated fatty acid anion and the conjugate base of octacosanoic acid (montanic acid), arising from deprotonation of the carboxy group.

   

(2R,4R,6R,8R)-2,4,6,8-tetramethyltetracosanoate

(2R,4R,6R,8R)-2,4,6,8-tetramethyltetracosanoate

C28H55O2- (423.42018299999995)


   
   

N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]hexanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxytricosa-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxytricosa-4,8-dien-2-yl]propanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]heptanamide

N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]heptanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxyhenicosa-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1,3-dihydroxyhenicosa-4,8-dien-2-yl]pentanamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptadec-9-enamide

(Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptadec-9-enamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]nonanamide

N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]nonanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxytetracosa-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxytetracosa-4,8-dien-2-yl]acetamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]butanamide

C26H49NO3 (423.3712244000001)


   

(9Z,12Z)-N-(1,3-dihydroxynonan-2-yl)heptadeca-9,12-dienamide

(9Z,12Z)-N-(1,3-dihydroxynonan-2-yl)heptadeca-9,12-dienamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]octanamide

N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]octanamide

C26H49NO3 (423.3712244000001)


   

(9Z,12Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-9,12-dienamide

(9Z,12Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-9,12-dienamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadec-9-enamide

(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadec-9-enamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetradec-9-enamide

(Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetradec-9-enamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetradecanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetradecanamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentadec-9-enamide

(Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentadec-9-enamide

C26H49NO3 (423.3712244000001)


   

(9Z,12Z)-N-(1,3-dihydroxydecan-2-yl)hexadeca-9,12-dienamide

(9Z,12Z)-N-(1,3-dihydroxydecan-2-yl)hexadeca-9,12-dienamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadec-9-enamide

(Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadec-9-enamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]decanamide

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]decanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]undecanamide

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]undecanamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]tridec-9-enamide

(Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]tridec-9-enamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]tridecanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]tridecanamide

C26H49NO3 (423.3712244000001)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]dodecanamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]dodecanamide

C26H49NO3 (423.3712244000001)


   

(Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]dodec-5-enamide

(Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]dodec-5-enamide

C26H49NO3 (423.3712244000001)


   

N-[(2S,3R,4E,6E)-1,3-dihydroxytetradeca-4,6-dien-2-yl]dodecanamide

N-[(2S,3R,4E,6E)-1,3-dihydroxytetradeca-4,6-dien-2-yl]dodecanamide

C26H49NO3 (423.3712244000001)


   

N-[(2S,3R,4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]decanamide

N-[(2S,3R,4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]decanamide

C26H49NO3 (423.3712244000001)


   

N-[(2S,3R,4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]dodecanamide

N-[(2S,3R,4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]dodecanamide

C26H49NO3 (423.3712244000001)


   

N-[(2S,3R,4E,6E)-1,3-dihydroxyhexadeca-4,6-dien-2-yl]decanamide

N-[(2S,3R,4E,6E)-1,3-dihydroxyhexadeca-4,6-dien-2-yl]decanamide

C26H49NO3 (423.3712244000001)


   

fatty acid anion 28:0

fatty acid anion 28:0

C28H55O2 (423.42018299999995)


Any saturated fatty acid anion containing 28 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.

   

Cer(26:2)

Cer(d14:2_12:0)

C26H49NO3 (423.3712244000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Amylamine 23:0

NA-Amylamine 23:0

C28H57NO (423.4439912)


   
   
   
   
   
   
   
   
   

(2e)-n-[(2s)-1-(acetyloxy)propan-2-yl]-2-methylicos-2-enimidic acid

(2e)-n-[(2s)-1-(acetyloxy)propan-2-yl]-2-methylicos-2-enimidic acid

C26H49NO3 (423.3712244000001)